–
Metagenomi Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY21:
FY22:
–
FY23:
−91.4
FY24:
−109
FY25:
−88.9
Change from FY21 to FY25
millions USD
FY21:
−74.3
FY22:
−122
FY23:
45.7
FY24:
−88.2
FY25:
104
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
1.01
FY24:
84.0
FY25:
−0.36
millions USD
FY21:
–
FY22:
–
FY23:
−44.7
FY24:
−113
FY25:
14.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
21.4
FY22:
15.7
FY23:
−101
FY24:
−112
FY25:
−89.5
All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.